MarketPulse

flu vaccine

2 articles
The Motley FoolThe Motley Fool··Adria Cimino

Moderna Charts Post-Pandemic Course With Pipeline Diversification Strategy

Moderna shifts from pandemic revenues toward diversified pipeline including seasonal vaccines and oncology treatments, targeting cash breakeven by 2028 amid FDA progress on flu vaccine candidate.
MRNAFDA approvalmRNA technology
BenzingaBenzinga··Vandana Singh

FDA Accepts Moderna Flu Vaccine Application After Prior Rejection

FDA accepts Moderna's flu vaccine application after prior rejection, setting August priority review date. Stock surges 5.77% as company expands mRNA pipeline beyond COVID-19.
MRNAFBTXBIFDA approvalearnings beat